What is Vericel Corp Annual Revenue?

Vericel Corp Annual Revenue rose 20.1%, in the last year to $237.22 M. Its sector's average revenue growth for the last fiscal year was 7.48%.

What is Vericel Corp Annual Net Profit?

Vericel Corp Annual Net Profit rose 425.64% in the last year to $10.36 M. Its sector's average net profit growth for the last fiscal year was -32.62%.

What is Vericel Corp Price to Earning Ratio?

Vericel Corp Price to Earning Ratio is 186.76, higher than its sector PE ratio of 3.08.

What is Vericel Corp Stock Price?

Vericel Corp Stock Price fell 24.42% and underperformed its sector by 20.67% in the past year.

What is Vericel Corp Quarterly Revenue?

Vericel Corp Quarterly Revenue rose 15.97% YoY to $75.38 M. Its sector's average revenue growth YoY for the quarter was 5.95%.

What is Vericel Corp Quarterly Net profit?

Vericel Corp Quarterly Net profit rose 52.44% YoY to $19.81 M. Its sector's average net profit growth YoY for the quarter was -47.55%.

What is Vericel Corp Debt to Equity Ratio?

Vericel Corp Debt to Equity Ratio of 0.34 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Vericel Corp Return on Equity(ROE)?

Vericel Corp Return on Equity(ROE) for the last financial year was 4%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Vericel Corp Mutual Fund Holding?

Vericel Corp Mutual Fund Holding decreased by 0.09% in the last quarter to 85.97.

What is Vericel Corp Promoter Share Holding?

Vericel Corp Promoter Share Holding increased by 0.16% in the most recent quarter to 1.15%.

What is Vericel Corp Interest Coverage Ratio?

Vericel Corp Interest Coverage Ratio is 18.12, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

What is Vericel Corp Institutional Holding?

Vericel Corp Institutional Holding decreased by 0% in the last quarter to 105.05.

How is the Vericel Corp today?

The Vericel Corp today is trading in the down by -3.26% at 38.60.

How has Vericel Corp performed historically?

The Vericel Corp is currently trading down -3.26% on an intraday basis in the past week the index fell -13.49%. The index has been down -34.80% in the past quarter and fell -24.42% in the past year. You can view this in the overview section.

Vericel Corp XNAS: VCEL

Vericel Corp Live Share Price Today, Share Analysis and Chart

Name: Vericel Corp: Is Infosys Ltd. worth buying?
Item: Vericel Corp
Rating: 2.084889
Author: Trendlyne DVM scores

Expensive Performer

Download real time

38.60 -1.30 (-3.26%)

New 52W Low today

878.4K XNAS Volume

XNAS 08 Apr, 2025 5:30 PM (EDT)

Vericel Corp Key Metrics

My Metrics

Default

Market Capitalization High in industry Unavailable in chosen country	1,935.2
PE TTM High in industry Unavailable in chosen country	186.8
PEG TTM High in industry Unavailable in chosen country	0.4
Price to Book High in industry Unavailable in chosen country	6.6
Institutional holding current Qtr % High in industry Unavailable in chosen country	105.1
Revenue Growth Qtr YoY % Below industry Median Unavailable in chosen country	16
Operating Revenue growth TTM % Below industry Median Unavailable in chosen country	20.1
Net Profit Qtr Growth YoY % Below industry Median Unavailable in chosen country	52.4
Net Profit TTM Growth % High in industry Unavailable in chosen country	425.6
Operating Profit Margin Qtr % High in industry Unavailable in chosen country	24.5
Operating Profit Margin TTM % Below industry Median Unavailable in chosen country	1.9
Piotroski Score High in industry Unavailable in chosen country	6
Rel Perf vs Sector quarter% Unavailable in chosen country	-28
ROE Annual % High in industry Unavailable in chosen country	4
RoA Annual % High in industry Unavailable in chosen country	2.6

All financials are in USD Million and price data in USD

High Financial Strength

55.6 / 100

Expensive Valuation

16.5 / 100

Technically Neutral

39.2 / 100

Expensive Performer These stocks are strong in quality but with mid-range technical aspects. Their strong financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM

1Yr Price target upside is 69%

8 analysts

Check Before You Buy

Check P/E Buy Sell Zone

Not enough data available

Vericel Corp Stock Price Analysis

Day Price Range -3.3% 1 Day return Unavailable in chosen country	38.6 (LTP) 37.841.6 LowHigh
Week Price Range -13.5% 1 Week return Unavailable in chosen country	38.6 (LTP) 37.845 LowHigh
Month Price Range -22.1% 1 Month return Unavailable in chosen country	38.6 (LTP) 37.849.4 LowHigh
52 Week Price Range -24.4% 1 Year return Unavailable in chosen country	38.6 (LTP) 37.863 LowHigh

View full Share Price History

Vericel Corp Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Miss

Vericel Corp's Revenue was lower than average estimate 2 times in past 3 years

EPS forecast

QUARTER
ANNUAL

Current EPS

0.2

Avg. Estimate

0.3

Low Estimate

0.3

High Estimate

0.4

Current EPS

Avg. Estimate

Hit

EPS is expected to grow by 65.0% in FY25

Consensus Recommendation

8 ANALYST Recommendations

STRONG BUY

The consensus recommendation from 8 analysts for Vericel Corp is STRONG BUY

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

Vericel Corp Stock Analysis

Vericel Corp stock analysis with key metrics, changes, and trends.

Vericel Corp Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Revenue	$237.22 M	20.1%	positive	Annual Revenue rose 20.1%, in the last year to $237.22 M. Its sector's average revenue growth for the last fiscal year was 7.48%.
Annual Net Profit	$10.36 M	425.64%	positive	Annual Net Profit rose 425.64% in the last year to $10.36 M. Its sector's average net profit growth for the last fiscal year was -32.62%.
Price to Earning Ratio	186.76	-	negative	Price to Earning Ratio is 186.76, higher than its sector PE ratio of 3.08.
Stock Price	$38.60	-24.42%	negative	Stock Price fell 24.42% and underperformed its sector by 20.67% in the past year.
Quarterly Revenue	$75.38 M	15.97%	positive	Quarterly Revenue rose 15.97% YoY to $75.38 M. Its sector's average revenue growth YoY for the quarter was 5.95%.
Quarterly Net profit	$19.81 M	52.44%	positive	Quarterly Net profit rose 52.44% YoY to $19.81 M. Its sector's average net profit growth YoY for the quarter was -47.55%.
Debt to Equity Ratio	0.34	-	positive	Debt to Equity Ratio of 0.34 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
Return on Equity(ROE)	4.00 %	4%	negative	Return on Equity(ROE) for the last financial year was 4%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.
Mutual Fund Holding	85.97 %	-0.09%	negative	Mutual Fund Holding decreased by 0.09% in the last quarter to 85.97.
Promoter Share Holding	1.15 %	0.16%	positive	Promoter Share Holding increased by 0.16% in the most recent quarter to 1.15%.
Interest Coverage Ratio	18.12	-	positive	Interest Coverage Ratio is 18.12, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).
Institutional Holding	105.05 %	0%	negative	Institutional Holding decreased by 0% in the last quarter to 105.05.

VIEW LESS

Loading data..

Vericel Corp - Company Profile

What does Vericel Corp do?

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Gross Remuneration

2024

Gross Remuneration

Year

Vericel Corp Live Share Price Today, Share Analysis and Chart

New 52W Low today

Vericel Corp Key Metrics

Market Capitalization

PE TTM

PEG TTM

Rel Perf vs Sector quarter%

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

ROE Annual %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

RoA Annual %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Vericel Corp Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Vericel Corp Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Vericel Corp's Revenue was lower than average estimate 2 times in past 3 years

EPS forecast

EPS is expected to grow by 65.0% in FY25

Consensus Recommendation

The consensus recommendation from 8 analysts for Vericel Corp is STRONG BUY

Vericel Corp Stock Analysis

Vericel Corp stock analysis with key metrics, changes, and trends.

Annual Revenue rose 20.1%, in the last year to $237.22 M. Its sector's average revenue growth for the last fiscal year was 7.48%.

Annual Net Profit rose 425.64% in the last year to $10.36 M. Its sector's average net profit growth for the last fiscal year was -32.62%.

Price to Earning Ratio is 186.76, higher than its sector PE ratio of 3.08.

Stock Price fell 24.42% and underperformed its sector by 20.67% in the past year.

Quarterly Revenue rose 15.97% YoY to $75.38 M. Its sector's average revenue growth YoY for the quarter was 5.95%.

Quarterly Net profit rose 52.44% YoY to $19.81 M. Its sector's average net profit growth YoY for the quarter was -47.55%.

Debt to Equity Ratio of 0.34 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE) for the last financial year was 4%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding decreased by 0.09% in the last quarter to 85.97.

Promoter Share Holding increased by 0.16% in the most recent quarter to 1.15%.

Interest Coverage Ratio is 18.12, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

Institutional Holding decreased by 0% in the last quarter to 105.05.

Vericel Corp - Company Profile

What does Vericel Corp do?

Vericel Corp Management structure

Mr. Dominick C. Colangelo

Director, President and Chief Executive Officer

Mr. Joseph A. Mara

Chief Financial Officer

Mr. Jonathan D. Siegal

Vice President, Corporate Controller and Principal Accounting Officer

Vericel Corp Board of directors

Mr. Dominick C. Colangelo

Director, President and Chief Executive Officer

Dr. Paul K. Wotton,PhD

Independent Director

Dr. Robert L. Zerbe,M.D.

Chairman of the Board

Dr. Steven C. Gilman, PhD